3. Etiology
Many factors can cause injury to the pancreas.
Biliary tract disease
Trauma (postsurgical, abdominal),
Viral infections (mumps, HIV), penetrating duodenal
ulcer, cysts, abscesses, cystic fibrosis, Kaposi sarcoma,
Certain drugs (corticosteroids, thiazide diuretics, oral
contraceptives, sulfonamides, NSAIDs)
4.
5. Metabolic disorders (hyperparathyroidism,
hyperlipidemia, renal failure), and vascular diseases.
Pancreatitis may occur after surgical procedures on the
pancreas, stomach, duodenum, or biliary tract.
Pancreatitis can also occur after ERCP (Endoscopic
Retrograde Cholangio-Pancreatography)
In some cases, the cause is unknown (idiopathic).
7. Clinical Manifestations
Abdominal pain is the predominant symptom of acute
pancreatitis.
The pain is usually located in the left upper quadrant, but
it may be in the midepigastrium.
It commonly radiates to the back because of the
retroperitoneal location of the pancreas.
The pain has a sudden onset and is described as severe,
deep, piercing, and continuous or steady.
It is aggravated by eating and frequently has its onset when
the patient is recumbent; it is not relieved by vomiting
8. The pain may be accompanied by flushing, cyanosis, and
dyspnea.
The pain is due to distention of the pancreas, peritoneal
irritation, and obstruction of the biliary tract.
Nausea and vomiting
Low-grade fever
Leukocytosis
9. Hypotension
Tachycardia
Jaundice.
Abdominal tenderness with muscle guarding is common.
Bowel sounds may be decreased or absent.
Paralytic Ileus may occur and causes marked abdominal
distention.
The lungs are frequently involved, with crackles present.
Intravascular damage from circulating trypsin may cause areas
of cyanosis or greenish to yellow-brown discoloration of the
abdominal wall.
10. Grey Turner's signs :A bluish flank discoloration
Cullen's sign: A bluish periumbilical discoloration.
Shock may occur due to
Hemorrhage
Toxemia from the activated pancreatic enzymes
Hypovolemia as a result of fluid shift into the
retroperitoneal space .
11. Diagnostic Studies
History and physical examination
Serum amylase
Serum lipase
Two-hour urinary amylase and renal amylase clearance
Increased level of Blood glucose
Increased level of Triglycerides
12. Abdominal ultrasound
Endoscopic ultrasound
Contrast-enhanced CT (CECT) of the pancreas
Magnetic resonance cholangiopancreatography (MRCP)
Endoscopic retrograde cholangiopancreatography (ERCP)
Chest x-ray
13. Collaborative Management
Pain medication (e.g., morphine)
NPO with NG tube to suction
Albumin (if shock present)
IV calcium gluconate (10%) (if tetany present)
Lactated Ringer's solution
ranitidine (Zantac) or omeprazole (Prilosec)
Antibiotics (if necrotizing pancreatitis)
14. If shock is present, blood volume replacements are used.
Plasma or plasma volume expanders such as dextran or
albumin may be given.
Fluid and electrolyte imbalances are corrected with
lactated Ringer's solution or other electrolyte solutions.
Central venous pressure readings may be used to assist in
determination of fluid replacement requirements.
Vasoactive drugs such as dopamine (Intropin) may be used
to increase systemic vascular resistance in patients with
ongoing hypotension.
15. It is important to reduce or suppress pancreatic enzymes
to decrease stimulation of the pancreas and allow it to rest.
This is accomplished in several ways.
First, the patient is allowed to take nothing by mouth
(NPO).
Second, NG suction may be used to reduce vomiting and
gastric distention and to prevent gastric acidic contents
from entering the duodenum.
These measures suppress pancreatic secretion.
16. Certain drugs may also be used for this purpose.
Morphine: Relief of pain
nitroglycerin or papaverine: Relaxation of smooth muscles
and relief of pain
Antispasmodics:Decrease of vagal stimulation, motility,
pancreatic outflow (inhibition of volume and
concentration of bicarbonate and enzymatic secretion);
contraindicated in paralytic ileus
Carbonic anhydrase inhibit or (acetazolamide
[Diamox]:Reduction in volume and bicarbonate
concentration of pancreatic secretion
17. Antacids: Neutralization of gastric hydrochloric (HCl)
acid secretion and subsequent decrease in secretion,
which stimulates production and secretion of pancreatic
secretions
Histamine (H2)-receptor : Decrease in HCl acid secretion
(HCl acid stimulates pancreatic activity)
18. Nutritional Therapy
Initially the patient with acute pancreatitis is on NPO status to
reduce pancreatic secretion.
Depending on the severity of the pancreatitis, enteral feedings
or parenteral nutrition may be initiated.
If IV lipids are ordered, blood triglyceride levels need to be
monitored.
In cases of moderate to severe pancreatitis, the patient may
require enteral feeding via a jejunal feeding tube.
If severe nutritional deficiencies exist, parenteral nutrition may
be used .
19. When food is allowed, small, frequent feedings are given.
The diet is usually high in carbohydrate content because
that is the least stimulating to the exocrine portion of the
pancreas.
Intolerance to oral foods is suspected when the patient
reports increasing abdominal girth or has elevations in
serum amylase and lipase levels.
20. Complication
Pseudocyst : It is a cavity continuous with or surrounding
the outside of the pancreas. The pseudocyst is filled with
necrotic products and liquid secretions, such as plasma,
pancreatic enzymes, and inflammatory exudates.
Pancreatic abscess: It is a large fluid-containing cavity
within the pancreas. It results from extensive necrosis in
the pancreas. It may become infected or perforate into
adjacent organs.
21. The pulmonary complications are likely due to the
passage of exudate containing pancreatic enzymes from
the peritoneal cavity through transdiaphragmatic lymph
channels.
Enzyme-induced inflammation of the diaphragm occurs
with an end result being atelectasis caused by reduced
diaphragm movement.
Trypsin can activate prothrombin and plasminogen,
increasing the patient's risk for intravascular thrombi,
pulmonary emboli, and disseminated intravascular
coagulation.